Stemoxydine is a new molecule developed by the L'oreal research team which claims to treat hair loss and induce new growth. Laboratory and clinical tests conducted at the French facility of L'oreal have shown some promise: In a double blind trial versus placebo on 101 men aged between 18 and 55 years, once daily application of Stemoxydine 5% solution (6ml), showed an increase of 4% in hair density on the patients treated with Stemoxydine (represents an average of + 1700 hair) at the end of the 3 months. The molecule has been launched in anti hair loss preparations under various brand names including Dercos Neogenic. The product is currently priced on the higher end in its class and is available in Europe and with select clinics in Asia.